Key facts
- This page summarizes Thomas E. Timbie's Form 4 filing for TREACE MEDICAL CONCEPTS, INC. (TMCI).
- 4 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 22 Nov 2022, 20:00.
Thomas E. Timbie - 18 Nov 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)
- Reporting relationship
- Director
- Issuer ticker
- TMCI
- Reported as of
- 18 Nov 2022
- Net transaction value
- -$1,128,915
- SEC form
- 4
- Accepted by SEC
- 22 Nov 2022, 20:00:13 UTC
- Prior SEC filing
- 18 Nov 2022
- Next SEC filing
- 16 Dec 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lisa Taylor as Attorney-in-fact for Thomas Timbie
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Thomas E. Timbie filed Form 4 for TREACE MEDICAL CONCEPTS, INC. (TMCI) on 22 Nov 2022.
Change
- Previous filing in this sequence was filed on 18 Nov 2022.
- Current net transaction value: -$1,128,915.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TMCI
transaction
Common Stock
Sale
- Transaction value
- $852,092
- Shares
- -37,605
- Change %
- -2.7%
- Price
- $22.66
- Shares after
- 1,361,464
- Date
- 18 Nov 2022
- Ownership
- Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001
- Footnotes
- F1, F2
TMCI
transaction
Common Stock
Sale
- Transaction value
- $49,279
- Shares
- -2,101
- Change %
- -0.15%
- Price
- $23.46
- Shares after
- 1,359,363
- Date
- 18 Nov 2022
- Ownership
- Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001
- Footnotes
- F1, F3
TMCI
transaction
Common Stock
Sale
- Transaction value
- $4,947
- Shares
- -224
- Change %
- -0.02%
- Price
- $22.08
- Shares after
- 1,359,139
- Date
- 21 Nov 2022
- Ownership
- Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001
- Footnotes
- F1, F4
TMCI
transaction
Common Stock
Sale
- Transaction value
- $222,597
- Shares
- -10,070
- Change %
- -0.74%
- Price
- $22.10
- Shares after
- 1,349,069
- Date
- 22 Nov 2022
- Ownership
- Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001
- Footnotes
- F1, F5
TMCI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,295
- Date
- 18 Nov 2022
- Ownership
- Direct
- Footnotes
- F6
TMCI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 385,000
- Date
- 18 Nov 2022
- Ownership
- Pamela Timbie and Thomas Timbie as Trustees of the PAMELA F TIMBIE REV TRUST
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Footnote F2
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.250 to $23.230 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F3
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.250 to $23.610 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F4
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.010 to $22.180 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F5
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.020 to $22.640 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F6
Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on May 17, 2023 subject to Reporting Person's providing continued service to Issuer through the vesting date.